1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Stat5 induces androgen receptor ( AR) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Androgen receptor (AR) drives prostate cancer (PC) growth and progression, and targeting AR signaling is the mainstay of pharmacological therapies for PC. Resistance develops relatively fast as a result of refueled AR activity. A major gap in the field is the lack of understanding of targetable mechanisms that induce persistent AR expression in castrate-resistant PC (CRPC). This study uncovers an unexpected function of active Stat5 signaling, a known promoter of PC growth and clinical progression, as a potent inducer of AR gene transcription. Stat5 suppression inhibited AR gene transcription in preclinical PC models and reduced the levels of wild-type, mutated, and truncated AR proteins. Pharmacological Stat5 inhibition by a specific small-molecule Stat5 inhibitor down-regulated Stat5-inducible genes as well as AR and AR-regulated genes and suppressed PC growth. This work introduces the concept of Stat5 as an inducer of AR gene transcription in PC. Pharmacological Stat5 inhibitors may represent a new strategy for suppressing AR and CRPC growth.

          Abstract

          Pharmacological Stat5 inhibition provides a strategy to suppress androgen receptor gene transcription and prostate cancer growth.

          Related collections

          Most cited references86

          • Record: found
          • Abstract: found
          • Article: not found

          Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

          Although genomewide RNA expression analysis has become a routine tool in biomedical research, extracting biological insight from such information remains a major challenge. Here, we describe a powerful analytical method called Gene Set Enrichment Analysis (GSEA) for interpreting gene expression data. The method derives its power by focusing on gene sets, that is, groups of genes that share common biological function, chromosomal location, or regulation. We demonstrate how GSEA yields insights into several cancer-related data sets, including leukemia and lung cancer. Notably, where single-gene analysis finds little similarity between two independent studies of patient survival in lung cancer, GSEA reveals many biological pathways in common. The GSEA method is embodied in a freely available software package, together with an initial database of 1,325 biologically defined gene sets.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

            Summary: It is expected that emerging digital gene expression (DGE) technologies will overtake microarray technologies in the near future for many functional genomics applications. One of the fundamental data analysis tasks, especially for gene expression studies, involves determining whether there is evidence that counts for a transcript or exon are significantly different across experimental conditions. edgeR is a Bioconductor software package for examining differential expression of replicated count data. An overdispersed Poisson model is used to account for both biological and technical variability. Empirical Bayes methods are used to moderate the degree of overdispersion across transcripts, improving the reliability of inference. The methodology can be used even with the most minimal levels of replication, provided at least one phenotype or experimental condition is replicated. The software may have other applications beyond sequencing data, such as proteome peptide count data. Availability: The package is freely available under the LGPL licence from the Bioconductor web site (http://bioconductor.org). Contact: mrobinson@wehi.edu.au
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              HISAT: a fast spliced aligner with low memory requirements.

              HISAT (hierarchical indexing for spliced alignment of transcripts) is a highly efficient system for aligning reads from RNA sequencing experiments. HISAT uses an indexing scheme based on the Burrows-Wheeler transform and the Ferragina-Manzini (FM) index, employing two types of indexes for alignment: a whole-genome FM index to anchor each alignment and numerous local FM indexes for very rapid extensions of these alignments. HISAT's hierarchical index for the human genome contains 48,000 local FM indexes, each representing a genomic region of ∼64,000 bp. Tests on real and simulated data sets showed that HISAT is the fastest system currently available, with equal or better accuracy than any other method. Despite its large number of indexes, HISAT requires only 4.3 gigabytes of memory. HISAT supports genomes of any size, including those larger than 4 billion bases.
                Bookmark

                Author and article information

                Contributors
                Role: InvestigationRole: MethodologyRole: ValidationRole: Writing - original draft
                Role: ConceptualizationRole: InvestigationRole: MethodologyRole: ResourcesRole: Validation
                Role: InvestigationRole: Validation
                Role: ConceptualizationRole: Formal analysisRole: InvestigationRole: MethodologyRole: ValidationRole: VisualizationRole: Writing - review & editing
                Role: Formal analysisRole: MethodologyRole: SoftwareRole: Visualization
                Role: Investigation
                Role: Formal analysisRole: Software
                Role: InvestigationRole: ValidationRole: VisualizationRole: Writing - review & editing
                Role: ConceptualizationRole: Data curationRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: VisualizationRole: Writing - review & editing
                Role: ConceptualizationRole: InvestigationRole: Resources
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: SoftwareRole: ValidationRole: VisualizationRole: Writing - review & editing
                Role: InvestigationRole: MethodologyRole: Resources
                Role: ConceptualizationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: Writing - review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: SupervisionRole: VisualizationRole: Writing - review & editing
                Role: ConceptualizationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draft
                Journal
                Sci Adv
                Sci Adv
                sciadv
                advances
                Science Advances
                American Association for the Advancement of Science
                2375-2548
                01 March 2024
                28 February 2024
                : 10
                : 9
                : eadi2742
                Affiliations
                [ 1 ]Department of Pathology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
                [ 2 ]Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
                [ 3 ]Graduate Program in Molecular, Cellular, and Developmental Biology and Genetics, University of Minnesota, Minneapolis, MN 55455, USA.
                [ 4 ]Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455, USA.
                [ 5 ]Graduate Program in Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
                [ 6 ]Department of Urology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
                [ 7 ]Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
                [ 8 ]Department of Tumor Biology, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL 33612, USA.
                [ 9 ]Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.
                [ 10 ]Department of Urology, University of Minnesota, Minneapolis, MN 55455, USA.
                [ 11 ]Department of Pharmacology, Physiology and Cancer Biology, Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, PA 19107, USA.
                Author notes
                [* ]Corresponding author. Email: marja.nevalainen@ 123456jefferson.edu
                [†]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0002-9437-1958
                https://orcid.org/0000-0001-6022-029X
                https://orcid.org/0000-0001-6556-0461
                https://orcid.org/0000-0001-6423-7048
                https://orcid.org/0009-0009-6157-006X
                https://orcid.org/0000-0003-2946-0601
                https://orcid.org/0000-0003-2039-2737
                https://orcid.org/0000-0002-6898-9148
                https://orcid.org/0000-0002-9364-8572
                https://orcid.org/0000-0002-7827-5579
                https://orcid.org/0009-0008-8593-078X
                Article
                adi2742
                10.1126/sciadv.adi2742
                10901378
                38416822
                194008c4-d339-41c0-8b02-0f9703f4e123
                Copyright © 2024 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

                This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 14 April 2023
                : 24 January 2024
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: 1RO1CA2622570
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: 1RO1CA212097
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: 1RO1CA212097
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: 1RO1CA2622570
                Funded by: Wisconsin Cancer Showhouse MTN;
                Award ID: FP15437
                Categories
                Research Article
                Biomedicine and Life Sciences
                SciAdv r-articles
                Cancer
                Cancer
                Custom metadata
                Mjoy Toledo

                Comments

                Comment on this article